Menghan Liu
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Central nervous system multiple myeloma: An update for 2026.
Journal: Annals of hematology
Published: May 10, 2026
PGC-1α protects against MASH via Tim23-dependent inhibition of DRP1-mediated ferroptosis.
Journal: Cell death & disease
Published: August 08, 2025
Analysis of care-seeking and diagnosis delay among pulmonary tuberculosis patients in Beijing, China.
Journal: Frontiers in public health
Published: January 12, 2024
Sarocladium strictum meningoencephalitis in a hemophagocytic lymphohistiocytosis patient.
Journal: The Journal of infection
Published: March 06, 2023
Serum sCD25/ferritin ratio combined with MCP-1 is a valid predictor for identifying LAHS with HLH as the first manifestation.
Journal: Journal of cancer research and clinical oncology
Published: March 04, 2023
Macrophage activation syndrome in adults: Characteristics, outcomes, and therapeutic effectiveness of etoposide-based regimen.
Journal: Frontiers in immunology
Published: May 28, 2022
Effectiveness of a modified doxorubicin-etoposide-methylprednisolone regimen for the treatment of refractory or relapsed macrophage activation syndrome in adults.
Journal: Polish archives of internal medicine
Published: March 07, 2022
Serum ferritin is a good indicator for predicting the efficacy of adult HLH induction therapy.
Journal: Annals of medicine
Published: February 03, 2022
A Study on Early Death Prognosis Model in Adult Patients with Secondary Hemophagocytic Lymphohistiocytosis.
Journal: Journal of healthcare engineering
Published: January 09, 2022
Clinical Features and Prognostic Risk Prediction of Non-Hodgkin Lymphoma-Associated Hemophagocytic Syndrome.
Journal: Frontiers in oncology
Published: October 01, 2021
Last Updated: 09/26/2026